
Academic Journal
Q1Dermatologic Therapy
About Dermatologic Therapy
Dermatologic Therapy is a scholarly journal published by John Wiley and Sons Inc. SCImago 2025 lists it in Q1, with an SJR of 0.796 and H-index of 90.
Coverage: 1996-2026. Research categories: Dermatology (Q1); Medicine (miscellaneous) (Q2).
Verified field sources
- Editor(s): Hannah Wesley (Editor) — Official source; checked 2026-10-03. Editorial leadership listed under Edited By on the Wiley journal homepage; publisher role retained without assuming Editor-in-Chief.
Open-access policies and author information
Reported in the official DOAJ public CSV snapshot (2026-09-01), downloaded 2026-10-03. Record updated 2026-08-03. This snapshot does not establish today’s listing status or fee quotation.
Publisher policy links recorded by DOAJ
- Aims and scope ↗
- Editorial board ↗
- Instructions for authors ↗
- Peer-review policy ↗
- Publication fees ↗
- Fee waivers ↗
- Licence terms ↗
- Copyright policy ↗
- Preservation policy ↗
Source: DOAJ journal record. Journal metadata is distributed by DOAJ under CC0. Confirm current fees, tax, eligibility and waiver terms with the publisher.
Source-backed journal facts
Topics in published research
Dermatology and Skin Diseases; Autoimmune Bullous Skin Diseases; Dermatologic Treatments and Research; Psoriasis: Treatment and Pathogenesis; Nail Diseases and Treatments; melanin and skin pigmentation.
OpenAlex classifies topics from published works. These topics are not the publisher’s official aims and scope.
Source: OpenAlex source record. Retrieved 2026-10-03. Source record updated 2026-10-02. OpenAlex metrics are different from SCImago metrics and the Clarivate Journal Impact Factor.
Journal Metrics
Quartile, SJR and the listed SCImago H-index use the 2025 imported SCImago dataset. A quartile may vary by subject category. Values without a source or reporting year are unverified historical entries. Verify the current Journal Impact Factor with Clarivate or the publisher before using it.
Aims & Scope
The publisher’s official aims and scope have not yet been verified for this profile. Use the journal website to check subject fit and accepted article types before submitting.
Recent Research Articles
Latest publications matched automatically by ISSN.
Optimized the Removal Technique for Double‐Armed Sutures
ChunYiu Leung, Sien Mai, Ziqin Gan, Jianjian Li et al.
2026-01 · DOI: 10.1155/dth/7748680Risk of Relapse Upon Treatment Discontinuation in Rosacea: An Updated Systematic Review and Network Meta‐Analysis of Randomized Controlled Trials
Ilaria Trave, Francesco Bellinato, Ilaria Salvi, Andrea Priano et al.
2026-01 · DOI: 10.1155/dth/6697712Oat β‐Glucan Improves Skin Barrier Repair by Regulating EGFR Signaling Pathway
Xiaolong Jiang, Simin Wu, Shaolin Hong, Hankun Ren et al.
2026-01 · DOI: 10.1155/dth/9852011Approach to the Assessment and Management of Adult Patients With Prurigo Nodularis: A Canadian Consensus
H. Chih-ho Hong, Vimal H. Prajapati, Kim A. Papp, Carolyn Jack et al.
2026-01 · DOI: 10.1155/dth/1000685Advances in Atopic Dermatitis Management: The Role of Lebrikizumab
Saba Mushtaq, Hafsa Shuja, Hamza Yousuf Ibrahim, Syeda Farwa Zehra et al.
2026-01 · DOI: 10.1155/dth/1682557Objective and Subjective Assessments of the Response of Photobiomodulation Therapy Against Alopecia Areata
Yi-Shan Liu, Chun-Ying Wu, Jeng-Fung Hung, Cheuk-Kwan Sun et al.
2026-01 · DOI: 10.1155/dth/2661014Efficacy of Topical Propolis and Aloe vera Gel as an Adjuvant to Benzoyl Peroxide in Moderate Acne Vulgaris: A Randomized Controlled Trial
Imam Megantara, Yosi Yohanes Putra Tandi, Sobri Emigasando, Rima Adifusi Sando et al.
2026-01 · DOI: 10.1155/dth/8836260Oxymatrine‐Associated Clinical and Molecular Changes in Psoriasis: An Exploratory WGCNA‐Based Translational Study
Wenfei Luo, Wenbo Cai, Yangxu Ding, Huijuan Shi et al.
2026-01 · DOI: 10.1155/dth/4418305Dermoscopy in the Treatment Monitoring of Cutaneous Infectious Diseases: A Review
Andrea Calogero Trecarichi, Giuseppe Micali, Anna Elisa Verzì
2026-01 · DOI: 10.1155/dth/1679851Dupilumab Efficacy and Safety Among Different Ages and Age of Onset of Atopic Dermatitis: Real‐World Experience
Noha Mohammed Dawoud, Rogaiah Zuhair Sagr, Ahmed Mohammed Bin Mahfoz, Amany Mohammed El-Rebigi et al.
2026-01 · DOI: 10.1155/dth/4206466Tattoo Exposure and Immune‐Mediated Disease: Clinical Patterns, Latency, and Mechanisms: A Systematic Review
Gerardo Guilarte, Hyoungsun Park, Connor Gill, Khushnood Faraz et al.
2026-01 · DOI: 10.1155/dth/3312606Smoking and Nail Psoriasis: Examining the Connection in a Case‐Control Study
Safoura Shakoei, Fatemeh Heidari, Maryam Nasimi, Shahin Hamzelou et al.
2026-01 · DOI: 10.1155/dth/9055487Long‐Term Efficacy and Safety of Low‐Level Laser Therapy for Androgenetic Alopecia: A 12‐Month Prospective Trial
Jung-Won Shin, Kyungho Paik, Jung-Im Na, Bark-Lynn Lew et al.
2026-01 · DOI: 10.1155/dth/6621458Predictors of Early and Complete Skin Clearance (PASI100) in Patients With Psoriasis Receiving Biologic Therapy: A Real‐World Cohort Study
Güllü Gencebay, Didem Dizman, Sera Nur Yücesoy, Melisa Özay et al.
2026-01 · DOI: 10.1155/dth/3143741Construction of a Competing‐Risk Nomogram for Predicting Cause‐Specific Mortality in Cutaneous Verrucous Carcinoma: A Retrospective SEER‐Based Study
Siomui Chong, Liying Huang, Yu-Yen Yang, Santosh Chokkakula et al.
2026-01 · DOI: 10.1155/dth/3157109Assessing the Therapeutic Potential of GLP‐1 Receptor Agonists in Psoriasis and Other Skin Diseases: Insights From a Scoping Review and Mendelian Randomization Study
Xiafan Long, Yixuan Qiu, Zexu Lin, Yutong Liu et al.
2026-01 · DOI: 10.1155/dth/9612721Clinical and Trichoscopic Differentiation of Fibrosing Alopecia in a Pattern Distribution From Female Pattern Hair Loss: A Biopsy‐Confirmed Diagnostic Accuracy Study
Korn Triyangkulsri, Chaninan Kositkuljorn, Kanchana Leerunyakul, Suthinee Rutnin et al.
2026-01 · DOI: 10.1155/dth/4572946Proof of Concept: Home Self‐Monitoring of Atopic Skin State Toward Better Emollient Compliance
J. Le Digabel, C. Lauze, J. Filiol, R. Marinescu et al.
2026-01 · DOI: 10.1155/dth/3345481Open‐Label, Randomized Pilot Study to Evaluate Safety and Tolerability of a Novel Dermal Nanoparticulate Imiquimod Formulation in the Treatment of Actinic Keratosis
Berenice M. Lang, Sophie Luise Meiser, Isabella Hölzle, Jonas Pielenhofer et al.
2026-01 · DOI: 10.1155/dth/3892598Tildrakizumab for Systemic‐Treatment‐Eligible Plaque Psoriasis: A Retrospective Real‐World Study in Chinese Patients
Meijiao Xu, Jingwen Zhang, Xiaojian Chen, Ruochen Zhang et al.
2026-01 · DOI: 10.1155/dth/9941211Reviews
Community Reviews
Version History
October 4, 2026 at 9:05 pm
October 2, 2026